For all primary mouse hepatocytes in vitro assays, cryopreserved primary mouse hepatocytes (ThermoFisher cat. no. HMCPIS) were thawed and immediately plated for use in CHRM (ThermoFisher cat. no. CM7000), Williams Medium E supplemented with Hepatocyte Plating Supplement Pack (Serum-Containing). Plates were incubated at 37 °C in a humidified incubator at 5% CO2 atmosphere for 5 hours before changing to serum free media (William's E Maintenance Media -Without Serum). Plates were incubated at 37 °C in a humidified incubator at 5% CO2 atmosphere for all periods between active use.
Mice models:
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In vivo protein expression experiments for hEpo and Luc mRNAs were performed using CD-1 and BALB/C mouse models.
Method Details.
Sequence Design eGFP variants (G1-G4) were stochastically generated using only frequently used codons.
For hEpo, we obtained one mammalian codon-optimized sequence variant (ECO) (58) and eight variants generated by combining two unique sequences encoding the first 30 aminoacids (HA, HB) with four different variants of the remainder of the CDS (E1, E2, E3, E4). A larger set of Luc variants deterministically encoded each instance of a given amino acid throughout the coding sequence with the same single codon, with the set of 20 codons used differing between variants.
In all cases, the coding sequence was flanked by identical 5¢ and 3¢ untranslated regions (UTRs) capable of supporting high levels of protein expression ( Figure 1B) . Thus, total protein expression from these exogenous RNAs is determined by the combined impact of the primary coding sequence and the nucleotides used. For simplicity and ease of analysis, we designed firefly luciferase mRNA sequences based on simple one-to-one codon sets (i.e. each amino acid is encoded by the same codon at every instance of the amino acid (Table S3 ) that disfavored the use of rare codons). Regions of increased rare codon frequency have been shown to decrease protein expression and mRNA stability (1, 2). The hEpo protein contains a 9-amino acid (27 nucleotide) signal peptide sequence that is removed from the mature protein after targeting the protein to the endoplasmic reticulum (ER) for secretion. To evaluate whether codon choice had different effects in the signal peptide region, we tested sequence designs for hEpo in which a leader region of 30 amino acids was encoded using two distinct codon sets: L1 (an AU-rich codon set) and L2 (a GC-rich codon set) ( Figure 1C ). eGFP mRNAs were computationally designed by an algorithm written to stochastically sample the sequence space of a given peptide sequence.
mRNA Preparation: mRNA was produced by in vitro transcription (IVT) using T7 RNA polymerase using a linearized DNA template encoding the RNA polymerase promotor followed by 5' UTR, ORF, 3'UTR, and poly(A) tail. Cap 1 was installed to improve translation efficiency. The following combinations of nucleotides were used: all unmodified nucleotides; unmodified adenosine, cytidine, and guanosine with pseudouridine (Y), N 1 -methylpseudouridine (m 1 Y), or 5-methoxy-uridine (mo 5 U); or unmodified adenosine and guanosine with pseudouridine and 5-methyl-cytidine (Y/m 5 C). After purification, the mRNA was buffer exchanged into sodium citrate buffer and stored at -20 °C until use.
mRNA Transfection:
HeLa, Vero, BJ, AML12 and Primary Hepatocytes were seeded in 100uL per well of 96 well plates at a concentration of 2x10 5 cells/mL one day prior to transfection and incubated overnight under standard cell culture conditions. For transfection, 50ng of mRNA was lipoplexed with 0.5uL Lipofectamine-2000 (ThermoFisher cat. no 11668027), brought to a volume of 20uL with Opti-MEM (ThermoFisher cat. no. 5 31985062) and directly added to cell media. All transfections were performed in duplicate.
Expression Assays:
Single endpoint Luc expression assays were conducted 24 hours post transfection, unless otherwise specified. The Luc Assay System (Promega cat. no. E1501) was used as per manufacturer's suggested protocol with 100uL lysis buffer at 1:10 dilution with Luc assay reagent. Luminescence was measured on a Synergy H1 plate reader.
Single endpoint hEpo expression assays were conducted 24 hours post transfection, unless otherwise specified. The Human Erythropoietin Platinum ELISA kit (Affymetrix cat. no. BMS2035) was used per the manufacturer's suggested protocol.
Single-endpoint eGFP expression assays were conducted 24 hours post transfection, unless otherwise specified. Fluorescence was measured at an excitation wavelength of 488nm and emission wavelength of 509nm on a Synergy H1 plate reader.
Single endpoint interferon-beta (IFN-β) expression assays were conducted on cell supernatant 48 hours post transfection. The Human IFN-Beta ELISA kit (R&D Systems cat. no. 41410) was used as per manufacturer's suggested protocol.
Luc mRNAs with m 1 Y, mo 5 U, and a negative control mRNA lacking a poly(A) tail were electroporated into AML12 cells and both protein expression and RNA abundance was assayed at 1, 2, 3, 5, 18, and 24 hours. Luciferase expression was also determined for electroporated RNA at every hour from 1 to 6 hours post electroporation in order to ensure that delivery did not dramatically change the expression phenotype.
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In vivo studies:
We measured reporter protein expression from exogenous mRNA in CD-1 and BALB/C mouse models.
Lipid nanoparticle formulation of mRNA was performed through ethanol drop nanoprecipitation by mixing acidified RNA and lipids dissolved in ethanol at a 3:1 ratio (aqueous:ethanol) at a lipid molar ratio of 50:10:38.5:1.5 (ionizable : fusogenic : structural : PEG). After pH adjustment, the mRNA-loaded lipid nanoparticles were buffer exchanged into 1x PBS and stored at 4 °C until use. Final particle size and encapsulation were <100nm and >80%, respectively, with endotoxin below 10 EU/mL. Luc mRNAs were formulated in lipid nanoparticles at a concentration of 0.03mg/mL, administered intravenously to CD-1 mice at a dose of 0.15mg/kg of body mass and measured for expression by whole body Bioluminescence Imaging (BLI) at 6 hours post injection.
hEpo mRNAs were formulated in lipid nanoparticles at a concentration of 0.01mg/mL, administered intravenously to BALB/C mice at a dose of (0.05mg/kg of body weight and measured for serum hEpo concentration using Human Erythropoietin Quantikine IVD ELISA kit (R&D Systems cat. no. DEP00) at 6 hours post injection.
UV Melting
Absorbance was measured at 260nm on the Cary100 UV Vis Spectrometer as RNA, in 2mM Sodium citrate buffer (pH=6.5), was heated from 25˚C to 80˚C at a rate of 7 1˚C/minute, and then cooled from 80˚C to 25˚C at a rate of 1˚C/minute. This cycle was repeated three times in total. First derivative of absorbance values were then analyzed as a function of temperature.
SHAPE-MaP
All purified mRNAs were denatured at 80˚C for 3 minutes prior to analysis. After denaturation, RNAs were folded in 100mM HEPES, pH 8.0, 100mM NaCl and 10mM
MgCl2 for 15 minutes at 37˚C. All RNAs were then selectively modified with 10mM 1methyl-6-nitroisatoic anhydride (1M6) (Sigma-Aldrich cat no. S888079-250MG) for 5 minutes at 37˚C. Background (no SHAPE reagent) and denatured (SHAPE modified fully denatured RNA) controls were prepared in parallel.
After SHAPE modification, RNA was purified and fragmented using 15mM MgCl2 at 94˚C for 4 minutes. Purified fragments were then randomly primed with N9 primer at RNA-seq libraries were sequenced on the Illumina MiSeq. Raw sequencing data was analyzed using the publicly available ShapeMapper software (3). The resulting reactivity data were analyzed using a sliding window (median SHAPE) approach to quantify the degree of structure at each position in the RNA, as has previously been described (4).
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Quantification and Statistical Analysis.
Comparison of codon effects on translation
Luc expression values from 39 Luc variants were used in 865 pairwise comparisons between synonymous codons to yield p-value testing whether inclusion of specific codons impacted protein expression by ANOVA. Graph Pad software was used to determine p-values and p-values < 0.05 were considered significant.
Determination of Nearest-Neighbor Thermodynamic Parameters
UV-melting experiments were performed on 39 synthetic RNA duplexes with Y, m 1 Y, and mo 5 U instead of uridine. The duplex sequences were designed to enable the full thermodynamic parameters for the nearest neighbor free energy contributions for each modified nucleotide to be determined.
Raw data were collected through absorbance versus duplex melting temperature profiles over six different synthetic oligonucleotide concentrations in 1M NaCl, 10mM Na2HPO4, and 0.5mM Na2EDTA, pH 6.98 salt buffer. These data were then processed using Figure 6C ) in which rate terms for protein maturation and degradation were held constant and the translation efficiency and rate of RNA degradation were allowed to vary to find the best fit to the experimental data. Data fitting was done in python using the Scikit learn module.
Data availability.
Raw sequencing files (.fastq) and processed reactivities from the SHAPE-MaP structure probing experiment are deposited into GEO under the ID codes XXXXXXXXXX.
Contact for Reagent and Resource Sharing.
Further information and requests for resources and reagents should be directed to and will be fulfilled by Melissa J. Moore, Melissa.Moore@Modernatx.com 
Pearson correlations for percent U (red) and A (blue) vs protein expression in HeLa cells
(y-axis) across 30 nucleotide regions (x-axis) for computationally designed eGFP sequence variants. Values are the same as in Figure 6B . mRNA half-lives (t1/2 RNA) were calculated from the observed mRNA decay rates.
(C) Correlation between the computationally determined eGFP-degron mRNA half-lives determined by computational models that excluded ( Figure 6C ) or include ( Figure   S11B ) a term for delivery of the RNA.
Supporting Table S1. Nearest neighbor base pairing energies for modified nucleotides, related to Figure 3
Nearest-neighbor thermodynamic parameters along with the experimentally determined error for Watson-crick base pairs containing unmodified uridine (values from (7)), Y, m 1 Y, or mo 5 U. The modified nucleotide(s) for each nearest neighbor pair is highlighted in red. Parameters were derived by linear regression of UV-melting data from X short oligonucleotides containing global substitutions, as described in (7) . Supporting Table S2 . Table of C.
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